National guideline for the management of chancroid

Sexually Transmitted Infections

Volumn 75, Issue SUPPL. 1, 1999, Pages

  Mayaud, Philippe ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; CIPROFLOXACIN; ERYTHROMYCIN; FLEROXACIN; SPECTINOMYCIN;

ANTIBIOTIC THERAPY; BACTERIUM IDENTIFICATION; CLINICAL FEATURE; CLINICAL PROTOCOL; HAEMOPHILUS DUCREYI; HUMAN; LYMPHADENOPATHY; NECROSIS; PHIMOSIS; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING; ULCUS MOLLE;

EID: 0344563565     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Piot P, Holmes KK. Sexually transmitted diseases. In: Warren KS, Mahmoud AAF, eds. Tropical and geographical medicine. 2nd ed. Chapter 96, 894-910. New York: McGraw-Hill, 1990.
2. Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in male-female transmission of human immunodeficiency virus type 1. J Infect Dis 1991;163:233-9.
3. Ernst AA, Marvez-Valls E, Martin DH. Incision and drainage versus aspiration of fluctuant buboes in the emergency department during an epidemic of chancroid. Sex Transm Dis 1995;22:217-20.
4. Dangor Y, Ballard R, Exposto F, et al. Accuracy of clinical diagnosis of genital ulcer disease. Sex Transm Dis 1990;17: 184-9.
5. O'Farrell N, Hoosen AA, Coetzee KD, et al. Genital ulcer disease:accuracy of clinical diagnosis and strategies to improve control in Durban, South Africa. Genitourin Med 1994;70:7-11.
6. Ndinya-Achola JO, Kihara AN, Fisher LD, et al. Presumptive specific clinical diagnosis of genital ulcer disease (GUD) in a primary health care setting in Nairobi. Int J STD AIDS 1996;7:201-5.
7. Van Dyck E, Piot P. Laboratory techniques in the investigation of chancroid, lymphogranuloma venereum and donovanosis. Genitourin Med 1992;68:130-3.
8. Trees D, Morse S. Chancroid and Haemophilus ducreyi: an update. Clin Microbiol Rev 1995;8:357-75.
9. West B, Wilson SM, Changalucha J, et al. Simplified PCR for detection of Haemophilus ducreyi and diagnosis of chancroid. J Clin Microbiol 1995;33:787-90.
10. Webb RM, Curier M, Grillo D, et al. Chancroid detected by polymerase chain reaction. Arch Dermatol 1996;132:17-8.
11. Kimani J, Bwayo JJ, Anzala AO, et al. Low dose erythromycin regimen for the treatment of chancroid. East Afr Med J 1995;72:645-8.
12. Bogaerts J, Kerstens L, Martinez-Tello W, et al. Failure of treatment for chancroid in Rwanda is not related to human immunodeficiency virus infection: in vitro resistance of Haemophilus ducreyi to trimerhoprim-sulfamethoxazole. Clin Infect Dis 1995;20:924-30.
13. Behets FM, Liomba G, Lule G, et al. Sexually transmitted diseases and human immunodeficiency virus control in Malawi: a field study of genital ulcer disease. J Infect Dis 1995;171:451-5.
14. Knapp JS, Back AF, Babst AF, et al. In vitro susceptibilities of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid. Antimicrob Agents Chemother 1993; 37:1552-5.
15. Van Dyck E, Bogaerts J, Smet H, et al. Emergence of Haemophilus ducreyi resistance to trimethoprim-sulfamethoxazole in Rwanda. Antimicrob Agents Chemother 1994;38:1647-8
16. Plourde PJ, D'Costa LJ, Agoki E, et al. A randomized, double blind study of the efficacy of fleroxacin versus trimethoprim-sulfamethoxazole in men with culture-proven chancroid. J Infect Dis 1992;165:949-52.
17. Tyndall MW, Plourde PJ, Agoki E, et al. Fleroxacin in the treatment of chancroid:an open study in men seropositive or seronegative for the human immunodeficiency virus type 1, Am J Med 1993b;94:85S-8S.
18. Schmid GP. The treatment of chancroid. JAMA 1986;255: 1757-62.
19. Fransen L, Nsanze H, Plummer FA, et al. A comparison of single-dose spectinomycin with five days of trimethoprim-sulfamethoxazole for the treatment of chancroid. Sex Transm Dis 1987;14:98-101.
20. Guzman M, Guzman J, Bernal M. Treatment of chancroid with a single dose of spectinomycin. Sex Transm Dis 1992; 19:291-4.
21. Tyndall MW, Agoki E, Plummer FA, et al. Single dose azithromycin for the treatment of chancroid: a randomized comparison with erythromycin. Sex Transm Dis 1994;21: 231-4.
22. Tyndall M, Malisa M, Plummer FA, et al. Ceftriaxone no longer predictably cures chancroid in Kenya. J Inject Dis 1993a;167:469-71.
23. Moses S, Malonza, Tyndall M, et al. Randomized, double-blind, placebo controlled trial of erythromycin and ciprofloxacin in the treatment of chancroid. Abstract P368, 12th Meeting of the ISSTDR, International Congress of Sexually Transmitted Diseases, Seville, October 1997.
24. Centers for Disease Control and Prevention. 1997 Sexually transmitted diseases treatment guidelines. MMWR 1997: 1-116.
25. Lewis DA, Dangor Y, Ballard RC. Comparison of E-test with agar dilution for antimicrobial susceptibility testing of Haemophilus ducreyi. Abstract P367, 12th Meeting of the ISSTDR, International Congress of Sexually Transmitted Diseases, Seville, October 1997.
26. Schmid GP. Treatment of chancroid, 1989. Rev Infect Dis 1990;12(Suppl 6):S580-9.
27. Schulte JM, Schmid GP, Recommendations for treatment of chancroid, 1993, Clin Infect Dis 1995;20(suppl 1);S39-46.
28. Martin DH, Sargent SJ, Wendel GD Jr, et al. Comparison of azithromycin and ceftriaxone for the treatment of chancroid. Clin Infect Dis 1995;21:409-14.
29. Taylor DN, Pitarangsi C, Echeverria P, et al. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand. J Infect Dis 1985;152:1002-6.
30. Naamara W, Plummer FA, Greenblatt RM, et al. Treatment of chancroid with ciprofloxacin. Am J Med 1987;82(suppl 4A):317-20.